Headlines hit wires a little while ago from AstraZeneca CEO Pascal Soriot who issued comments on the EU's legal action against the firm over alleged breach of contract in not delivering enough COVID-19 vaccines to the EU. Below are more comprehensive remarks

" [...] we don't regret anything, we haven't been perfect but we did the very best, we should be proud of what we did in the world [...] we never overpromised the supply of vaccine doses [...] some countries have said they don't need our vaccine, but the world needs it. AZ welcomes the possibility to resolve discussion with EU on supply, but we are committed to increasing supply [...] if we see the glass full, without AstraZeneca there would have been no supply of Covid vaccines in India or for the Covax program. Our vaccine has already saved over 10,000 lives in the UK."

Homepage markets-real-time Political Risk Political Risk Bullet Bullet Markets Fixed Income News Foreign Exchange News

Tom Lake

Homepage markets-real-time Political Risk Political Risk Bullet Bullet Markets Fixed Income News Foreign Exchange News

To read the full story

Free Trial Log In

Sign up now for free access to this content.

Please enter your details below and select your areas of interest.

Enter your Country

Enter your Phone

Areas of interests

FI Market:

Focusing on the Fixed Income market, our specialist approach makes us a resource relied upon by the world’s most prominent financial market investors. Our real-time insight and intelligence is renowned for leading and shaping the debate on key market issues, giving our customers the edge in identifying short- and medium-term market trends.

Offers original, real-time commentary on the fixed income market, including live coverage from Chicago’s futures trading floor.
Focuses on trading flows, market sentiments, economic data, monetary & fiscal policy, central banks market activity, global capital flows and market intelligence.
Central bank previews and review reports
Comprehensive coverage of sovereign bond issuance
Includes FI Position Indicator and FI Technical Analysis.

FX Market:

Focusing on the Foreign Exchange market, our specialist approach makes us a resource relied upon by the world’s most prominent financial market investors. Our real-time insight and intelligence is renowned for leading and shaping the debate on key market issues, giving our customers the edge in identifying short- and medium-term market trends.

Minute by minute reporting on FX markets.
Central bank previews and review reports
Focuses on trading flows, central bank activity, FX options and cross-asset flows.
Includes FX Options Monitor, FX Position Indicator and FX Technical Analysis

Data:

As an accredited news agency and recognized by the world’s major central banks and national statistics agencies, MNI Market News is at the center of the financial market information infrastructure. Our succinct reporting approach allows for the identification of key data aspects at the time of release, trusted by traders and investors globally.

Policy:

Unrivalled Central Bank Policy coverage across G7 and China, delivering exclusive interviews with leading policymakers. We cut through the noise to convey the true policy message that impacts FX and Fixed Income markets.

MNI Research:

Actionable insight on monetary policy, balance sheet and inflation with focus on global issuance. Analysis on key political risk impacting the global markets.

Emerging Markets:

Coverage that offers real-time actionable intelligence, analysis and insight on fixed income and foreign exchange markets in CEMEA, Asia and LatAm regions delivered in concise bullet point format.

High Speed Calendar:

Provides economic data releases with ultra low-latency from a trusted news source, either web-based or via a direct API feed integrated into your trading platform, portal or quantitative model. The calendar covers over 500 economic data points, major central bank rate decisions along with bond auction results. The calendar also has customizable features allowing the user to tailor the display to their requirements and also individual trading timezones.

Commodities:

MNI’s Oil and Gas service offers real-time, actionable intelligence and insight on global oil and gas markets, delivered in concise bullet point format, either via the MNI website, Bloomberg or the ICE platform. It is complemented by our email service, which provides weekly analysis of the energy sector, market roundups ahead of each regional trading session, as well as comprehensive previews of all OPEC meetings. Our Oil and Gas team includes former energy traders, industry experts, political risk analysts and macroeconomists, with full analyst interaction available.

Offers real-time insight on market price action, including product spreads, options, swaps
Industry insight:

Production and Consumption dynamics
Inventories, Reserves, Independent stocks
Shipping
Projects
Refining

Real-time Political and Geopolitical risk analysis impacting the oil & gas markets.
Proprietary technical analysis on key oil & gas markets.
DOE & IEA data.

MNI may contact you in your professional capacity with information about our other products and services that we believe may be of interest to you. You will be able to update your communication preferences via the unsubscribe link provided within your communication.

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

We are facing technical issues, please contact our team.

Your request was sent sucessfully! Our team will contact you soon.

Real-time Actionable Insight

AstraZeneca CEO On EU Legal Action: 'We Never Overpromised'